Dashboard
Manage Tickers

ACHV ACHIEVE LIFE SCIENCES, INC.

Nasdaq achievelifesciences.com


$ 5.03 $ -0.04 (-0.79 %)    

Tuesday, 04-Nov-2025 09:45:08 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 624.01 $ 0.76 (0.12 %)
DIA $ 470.44 $ 0.08 (0.02 %)
SPY $ 676.97 $ 0.83 (0.12 %)
TLT $ 89.81 $ 0.02 (0.02 %)
GLD $ 362.15 $ -1.43 (-0.39 %)
$ 5.11
$ 5.05
$ 5.01 x 1
$ 5.05 x 1,001
$ 4.94 - $ 5.05
$ 1.84 - $ 5.78
942,875
na
261.15M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-13-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-01-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 07-31-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-12-2016 03-31-2016 10-Q
39 03-09-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

achieve-life-sciences-announces-key-nda-milestones-for-cytisinicline-co-submits-120-day-update-to-fda-concludes-orca-ol-safety-trial-dsmc-finds-no-safety-concerns-for-cytisinicline
Achieve Life Sciences Announces Key NDA Mi...
11/03/2025 13:41:03

Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and ...

4-biotech-stocks-lifting-off-as-momentum-builds
4 Biotech Stocks Lifting Off As Momentum B...
10/21/2025 15:49:39

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

fda-unveils-first-experimental-drugs-under-fast-track-voucher-plan-to-cut-drug-review-times
FDA Unveils First Experimental Drugs Under...
10/17/2025 14:03:18

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, a...

achieve-life-sciences-receives-fda-commissioners-national-priority-voucher-for-cytisinicline-in-e-cigarettevaping-cessationone-of-nine-in-inaugural-program-enabling-12-month-expedited-review
Achieve Life Sciences Receives FDA Commiss...
10/17/2025 11:33:27

why-csx-shares-are-trading-higher-by-over-4-here-are-20-stocks-moving-premarket
Why CSX Shares Are Trading Higher By Over ...
10/17/2025 09:55:54

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 21:06:04

achieve-life-sciences-publishes-new-data-in-thorax-entitled-cytisinicline-for-smoking-cessation-in-individuals-with-self-reported-copd-a-post-hoc-analysis-of-the-orca-2-and-orca-3-trials
Achieve Life Sciences Publishes New Data I...
09/22/2025 12:38:00

achieve-life-sciences-appoints-craig-donnelly-to-coo
Achieve Life Sciences Appoints Craig Donne...
09/18/2025 12:32:56

- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development an...

fda-accepts-achieve-life-sciences-cytisinicline-new-drug-application-for-treatment-for-smoking-cessation-in-adults
FDA Accepts Achieve Life Sciences' Cytisin...
09/03/2025 12:32:38

achieve-life-sciences-inches-closer-to-fda-nod-for-first-new-quit-smoking-drug-in-20-years
Achieve Life Sciences Inches Closer To FDA...
08/21/2025 18:11:26

HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a lar...

hc-wainwright--co-initiates-coverage-on-achieve-life-sciences-with-buy-rating-announces-price-target-of-12
HC Wainwright & Co. Initiates Coverage On ...
08/21/2025 11:10:08

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating a...

achieve-life-sciences-q2-eps-037-beats-038-estimate
Achieve Life Sciences Q2 EPS $(0.37) Beats...
08/07/2025 11:30:31

Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
06/27/2025 17:05:50

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/27/2025 12:07:16

reported-earlier-achieve-life-sciences-prices-45m-public-offering-of-15m-shares-and-15m-accompanying-warrants-at-3-each
Reported Earlier, Achieve Life Sciences Pr...
06/27/2025 06:19:13

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
06/26/2025 21:05:50

achieve-life-sciences-announces-proposed-underwritten-public-offering-size-not-disclosed
Achieve Life Sciences Announces Proposed U...
06/26/2025 20:04:21

achieve-life-sciences-submits-nda-to-fda-for-cytisinicline-as-a-treatment-for-nicotine-dependence-for-smoking-cessation
Achieve Life Sciences Submits NDA To FDA F...
06/26/2025 20:03:03

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION